ELV Elevance Health PE ratio, current and historical analysis
The PE ratio for Elevance Health stock stands at 15.57 as of Feb 25, 2025. This is calculated based on the current EPS of $25.81 and the stock price of $401.93 per share. A decrease of 13% has been seen in the P/E ratio compared to the average of 17.9 of the last 4 quarters.
ELV PE ratio history
Over the last ten years, the average PE ratio of Elevance Health has been 16.5. The current 15.57 PE ratio is 6% below the historical average. Over the past ten years, ELV's PE ratio was at its highest in the Jun 2021 quarter at 22.09, with a price of $381.8 and an EPS of $17.28. The Jun 2020 quarter recorded the bottom point at 11.24, with a price of $262.98 and an EPS of $23.39.
Elevance Health PE ratio by year
Maximum annual increase: 50.14% in 2013
Maximum annual decrease: -23.09% in 2024
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | 14.29 | -23.09% | $368.9 | $25.81 |
| 2023 | 18.58 | -11.06% | $471.56 | $25.38 |
| 2022 | 20.89 | 13.84% | $512.97 | $24.56 |
| 2021 | 18.35 | 4.2% | $463.54 | $25.26 |
| 2020 | 17.61 | 9.65% | $321.09 | $18.23 |
| 2019 | 16.06 | -11.17% | $302.03 | $18.81 |
| 2018 | 18.08 | 18.09% | $262.63 | $14.53 |
| 2017 | 15.31 | 0% | $225.01 | $14.7 |
| 2016 | 15.31 | 6.84% | $143.77 | $9.39 |
| 2015 | 14.33 | 6.15% | $139.44 | $9.73 |
| 2014 | 13.5 | 21.84% | $125.67 | $9.31 |
| 2013 | 11.08 | 50.14% | $92.39 | $8.34 |
| 2012 | 7.38 | -18.09% | $60.92 | $8.26 |
| 2011 | 9.01 | 11.37% | $66.25 | $7.35 |
| 2010 | 8.09 | 38.29% | $56.86 | $7.03 |
Elevance Health PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Dec 2024 | 14.29 | -24.11% | $368.9 | $25.81 |
| Sep 2024 | 18.83 | -0.21% | $520 | $27.62 |
| Jun 2024 | 18.87 | -3.03% | $541.86 | $28.72 |
| Mar 2024 | 19.46 | 4.74% | $518.54 | $26.64 |
| Dec 2023 | 18.58 | 8.09% | $471.56 | $25.38 |
| Sep 2023 | 17.19 | 2.69% | $435.42 | $25.33 |
| Jun 2023 | 16.74 | -7.1% | $444.29 | $26.54 |
| Mar 2023 | 18.02 | -13.74% | $459.81 | $25.51 |
| Dec 2022 | 20.89 | 18.76% | $512.97 | $24.56 |
| Sep 2022 | 17.59 | -7.62% | $454.24 | $25.83 |
| Jun 2022 | 19.04 | 0.26% | $482.58 | $25.34 |
| Mar 2022 | 18.99 | 3.49% | $491.22 | $25.87 |
| Dec 2021 | 18.35 | 11.21% | $463.54 | $25.26 |
| Sep 2021 | 16.5 | -25.31% | $372.8 | $22.6 |
| Jun 2021 | 22.09 | 16.75% | $381.8 | $17.28 |
ELV average PE ratio chart
The current PE ratio of ELV is below the 3, 5 and 10-year averages.
ELV PE vs peers
ELV's PE ratio is lower than its peer stock OSCR, but it is greater than PFG's.
| Stock name | PE ratio | Market cap |
|---|---|---|
| PFG Principal Financial Group Inc | 12.73 | $19.44B |
| ELV Elevance Health Inc | 15.15 | $88.88B |
| OSCR Oscar Health Inc | 142.27 | $3.92B |
| LIFW MSP Recovery Inc | N/A | $14.7M |
| NEUE NeueHealth Inc. | N/A | $60.64M |
Frequently asked questions
What is Elevance Health's PE ratio?
The price to earnings ratio for ELV stock as of Feb 25, 2025, stands at 15.57.
What is the 3-year average PE ratio for Elevance Health (ELV)?
The 3-year average PE ratio for ELV stock is 18.21.
What is the 5-year average PE ratio for Elevance Health (ELV)?
The 5-year average PE ratio for ELV stock is 17.45.
What is the highest PE ratio for ELV?
The highest quarterly PE ratio in the last ten years has been 22.09 and it was in the Jun 2021 quarter.
How does the current PE ratio for ELV compare to its historical average?
The current price to earnings ratio of ELV is 6% lower than the 10-year historical average.
How is ELV's PE ratio calculated (Elevance Health PE ratio formula)?
The PE ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (Feb 25, 2025), Elevance Health's stock price is $401.93. The earnings per share for the trailing twelve months (TTM) ending Dec 2024 is $25.81. Therefore, Elevance Health's P/E ratio for today is 15.57. PE RATIO(15.57) = STOCK PRICE($401.93) / TTM EPS($25.81)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.